SOAT1 and rheumatoid arthritis: Interstitial lung disease (ILD) is the most common pulmonary manifestation of RA, and resveratrol treatment was found to alleviate RA-ILD in rats by inhibiting the JAK/STAT/RANKL signaling pathway (Yang et al., 2019).